美国 · 平台与数据 · MarketBeat

Ultragenyx Pharmaceutical Inc. (RARE) - What Are Investment Firms Saying About This Stock?

来源：MarketBeat · 美国 35 分钟前

Image from MarketBeat Media, LLC. · MarketBeat

详细摘要

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE - Get Free Report) has received an average recommendation of "Hold" from the twenty-two research firms that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, eleven have assigned a ho

在 MarketBeat 阅读全文登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.marketbeat.com)

Ultragenyx Pharmaceutical Inc. (RARE) - What Are Investment Firms Saying About This Stock?

详细摘要

推荐阅读

Nvidia is gearing up for one of Wall Street’s most anticipated earnings calls in years

Huang weighs Nvidia return as investors urge board to keep options open

Tanker in New Orleans ship collision suffered ’steering casualty,’ NTSB says

Lutnick faces questions over Nvidia spy scandal. His sons' firm has ties to the chipmaker

Berry Street Welcomes MyScribe Founder Dr. Wasif Bokhari to Its AI Team and Acquires MyScribe

Fonterra Shareholders’ Fund Annual Meeting Covers FY26 Results and Mainland Divestment

Ultragenyx Pharmaceutical Inc. (RARE) - What Are Investment Firms Saying About This Stock?

详细摘要

分享

推荐阅读

Nvidia is gearing up for one of Wall Street’s most anticipated earnings calls in years

Huang weighs Nvidia return as investors urge board to keep options open

Tanker in New Orleans ship collision suffered ’steering casualty,’ NTSB says

Lutnick faces questions over Nvidia spy scandal. His sons' firm has ties to the chipmaker

Berry Street Welcomes MyScribe Founder Dr. Wasif Bokhari to Its AI Team and Acquires MyScribe

Fonterra Shareholders’ Fund Annual Meeting Covers FY26 Results and Mainland Divestment